glp-1 drugs and lupus Ozempic Lupus: Is It Safe To Take? Understanding Case Reports and Their
Description
Le Quotidien du Pharmacien
doi: 10.1007/s10620-025-08964-6 104 AndersonSRAyoubMCoatsSMcHenrySTanTDeepakP
In keeping with GLP1-mediated brain targeting, quantitative proteomics reveals changes in common and distinct hypothalamic pathways in response to GLP1/E between the two PCOS models, as basis for differential efficiency
Montanya, E
Together with the expected decrease of body mass index (BMI), waist circumference, and glycemic markers, a number of studies confirmed a reduction of inflammatory markers such as IL17 and TNF-, reinforcing the immunomodulatory action of GLP-1RAs, both in murine (56) and human models (55)
